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Abstract
Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders. 
The aim of this study was to find the correlation between color Doppler ultrasound 
and serum tests as auxiliary diagnostic criteria in areas where there is no possibility of 
some tests. A total of 108 patients were enrolled. They were divided into three groups 
including patients with PCOS, patients with PCOA ultrasound, patients with ovaries and 
normal hormone tests. Transvaginal sonography was performed from three groups and 
the results were evaluated in gray scale. The volume of the ovary, the number of follicles 
and the placement of follicles were recorded using using Doppler spectrum of uterine 
artery and ovarian stroma. Their arterial resistance index was also calculated. In the next 
step, serum samples were evaluated to determine the level of LH, FSH, free testosterone, 
DHEAS and 17-OHP hormones in the early follicular phase. Gray scale ultrasonographic 
findings (volume and number of ovarian follicles) as well as LH values were higher 
in patients with PCOS than those in the other two groups. These results proved the 
reliability of using these factors in the prediction of PCOS. In this study, Doppler indexes 
did not correlate with the size of the ovaries, the number of ovarian follicles and the 
measured hormone levels. The findings of transvaginal ultrasound and investigating 
the relationship with clinical and laboratory outcomes, a more suitable pattern could 
be chosen for more accurate patient selection and, leading to timely treatment and 
reducing the complications of the disease.
Introduction
Polycystic ovarian syndrome (PCOS) is one of the most 
common endocrinopathies in humans, which affects five 
to ten percent of women in childbearing age (1). About 
20 to 30 percent of women in reproductive age show 
polycystic ovaries in ultrasound (2). The three main causes 
of these patients’ referral are infertility (74%), irregular 
menstrual cycles (66%) and an increase in the level of 
androgens (48%) (3). It has been defined that infertility 
was one of the main complaints related to PCOS (4). 
Much epidemiologic evidence suggests that PCOS is the 
most common cause of ovarian dysfunction (POI), which 
is associated with an increased risk of infertility (5).
Insulin resistance and obesity are also considered to 
be PCOS disorders and independently increase the risk 
of abortion and reduce the probability of pregnancy and 
the birth of a live fetus (6). The risk of hyperplasia and 
endometrial cancer is higher in women with PCOS. This 
is due to the unopposed estrogen along with ovulation 
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cycles, the lack of progesterone inhibition on endometrial 
proliferation and the absence of differentiation into the 
secretion phase (7). Of course, PCOS should no longer 
be considered just as a gynecologic condition, because 
many of these women are still at risk of developing 
cardiovascular disease (8), due to many factors such as 
obesity, insulin resistance, high blood pressure and fat (9), 
where a 7.4-fold increase in their mortality was estimated 
(10).
In multiple analyses the risk of pregnancy, preeclampsia 
and gestational diabetes mellitus in PCOS women is at 
least three times higher (11). The risk of early delivery in 
these individuals is at least double, and their infants have 
had twice the risk of NICU admission; moreover, their 
mortality rate is also tripled (12). In addition to metabolic 
and cardiovascular disorders, psychological disorders 
and a decrease in the quality of life can be observed in 
PCOS patients, compared to healthy women, where 
they are more at risk for depression and anxiety (13). 
Determination of diagnostic criteria for PCOS plays a key 
role in early diagnosis and treatment of this condition.
Since the polycystic ovary is an important component 
of the clinical manifestation, it should be noted that the 
intra-observer variability and inter have been reported in 
ultrasound (15). Therefore, the addition of more diagnostic 
cryotherapy to ultrasound assessment can be very helpful 
in diagnostic and therapeutic decision making. The total 
number of follicles and their distribution in gray scale 
ultrasound are two examples. On the other hand, it has 
been shown that significant changes have been occurred 
in vascularization of the ovary and in the surface of the 
ovarian arteries in patients with PCOS. On the other hand, 
finding the association between increased androgens and 
biochemical tests with PCOS ultrasound criteria can be a 
confirmation stamp for a more accurate diagnosis, as well 
as a better fit for follow-up, treatment and reducing the 
number of suspected cases (16).
Consideration should be given to some issues such as 
the increasing incidence of PCOS, the lack of diagnostic 
criteria in this issue, the controversial nature of the 
diagnosis of this syndrome or the high cost of serological 
tests. If these Doppler ultrasonographic criteria have 
a meaningful relationship with serum hormone tests, 
then these criteria could be considered as an auxiliary 
diagnostic criterion in areas where these tests are not 
available. Therefore, in this study, we tried to explore the 
ultrasound criteria of this syndrome in comparison with 
those who did not have any criteria and to improve the 
diagnostic criteria of this syndrome, where can be easily 




The study was conducted according to the guidelines laid 
down in the Declaration of Helsinki, and all procedures 
were approved by the Iran University of Medical Science 
Ethics Committee and the. Written informed consent was 
obtained from all patients.
This case–control study was performed using 
convenience sampling method. The population for 
entering the research was those who referred to the 
department of obstetrics and gynecology, Akbar-Abadi 
Hospital, Tehran between 2013 and 2014 for various 
reasons such as infertility and having ultrasound criteria 
for PCOS.
Exclusion criteria
A) Individuals with systemic conditions include: 
(1) hypertension above 140/90 mmHg; (2) increased 
blood lipids; (3) hyperprolactinemia.
B) People with metabolic diseases included (1) diabetes; (2) 
thyroid problems; (3) adrenals; (4) insulin resistance; 
(5) acanthose HAIRAN syndrome: hyperandrogenic 
insulin-resistant acanthosis nigricans.
C) Consumers of anti-lepitic drugs such as: (1) Valproic 
acid; (2) high-dose exogenous androgens; (3) oral 
contraceptive pills.
D) Individuals with androgen-secreting tumors.
E) Subjects with congenital adrenal hyperplasia.
F) People with Cushing’s syndrome and people who 
have undergone hormonal treatments during the past 
6 months.
The reasons for the exclusion of subjects from the plan 
was recorded as clear as possible to determine the impact 
of them and the probable degree of bias and to determine 
their impact on the results by performing sensitivity 
analysis. Overall, 108 subjects entered the study. Written 
consents were taken from people who had eligibility 
criteria and a complete history was obtained to assess the 
level of TSH, free T4, triglyceride, cholesterol and so forth. 
Moreover, ultrasound was performed by Siemens Sonoline 
G50 Ultrasound with Probe, and ultrasonographic, 
demographic laboratory data were recorded in the 
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questionnaire. Transvaginal ultrasonography (TVU) was 
performed in early follicular phase (between two and five 
cycles), and then the patients were tested for serum levels 
of luteinizing hormones, FSH, prolactin (PRL), estradiol, 
free testosterone, 17α-hydroxyprogesterone (17-OHP) and 
DHEAS.
To reduce the effects of external factors on blood flow, 
all patients had a 15-min rest in the waiting room before 
starting the Doppler and completely empty their bladder. 
The Ferriman–Gallwey scale hirsutism was measured for 
the participants of the study as modified by Hatch et al. 
(17), and the subjects were finally divided into three 
groups:
Group 1: Patients with PCOS according to Rotterdam 
diagnostic criteria, where clinical and hormonal condition 
were normal (PCOS: 45 subjects).
People who exhibited a sonographic picture of the 
polycystic ovary, while were clinically and hormonally 
normal (PCO appearance: 31 subjects).
Group 3: Individuals who had normal sonography of 
the ovaries with normal clinical condition and normal 
hormonal profiles (32 subjects).
Patient’s history, clinical examinations and 
demographic factors, menstruation, hirsutism were 
recorded in the questionnaire. A number of variable were 
investigated in the gray scale including the involved 
ovarian variables, ovarian volume, number of follicles 
and placement of follicles. Furthermore, the volume 
of both ovaries was also calculated using the following 
formula: thickness × width × length × 0.523. The number of 
follicles was counted in both the anterior and posterior 
sections of the ovary, and the colon Doppler revealed 
uterine artery in the cervico-corporial junction and the 
resistance index (RI) of the uterine artery was examined 
and recorded separately. By using low pulse repetition 
frequency setting, a low wall filter and optimum gain, 
ovarian stromal vascularity and RI were obtained.
Statistical analysis
In order to evaluate the qualitative variables, frequency 
was used and quantitative variables such as arterial RI, 
age and mean were presented by standard deviation. 
Comparison of RIs in PCOS, PCOA and normal group were 
performed using t-test and Mann–Whitney U depending 
on the existence or non-existence of parametric statistical 
tests. Comparison of these arterial indexes with other 
quantitative variables, such as age was conducted using 
partial correlation tests in order to eliminate the effect 
of confounding factors on the two variables. In order 
to indicate the severity of this relationship, correlation 
coefficients such as Pearson, Kendall or other coefficients 
were applied based on the requirements and conditions 
of the variables. Linear regression (stepwise model) and 
logistic regression (Forward-Wald) model were used to 
predict independent factors affecting the resistance of the 
arteries. The ROC curve was also plotted to determine the 
best cutting point based on the criteria obtained for PCOS 
diagnosis.
Results
A total of 108 people were enrolled in the study, of which 
45 were randomized based on the Rotterdam criteria in the 
PCOS group, followed by 31 patients for the PCOA group 
(PCO appearance) and 32 subjects for the normal group 
(clinically and sonographically normal). The mean age 
for subjects in the PCOS group was 28.1 years, followed 
by 31 years for the PCOA group and 32 for the normal 
group. The mean BMI was calculated in PCOS (28.1 ± 4.6), 
PCOA (25.7 ± 3.7) and normal groups (24.3 ± 3.8) in kg/m2. 
BMI in the PCOS group was higher than the other two 
groups, where showed a significant difference (P ≤ 0.01). 
Regarding menstruation status, in the group of PCOS, out 
of 45 subjects 5 (11.2%) had regular menstrual periods 
and 40 others (88.8%) had menstrual disorder.
Among all subjects enrolled in group PCOA, of 
31 patients, 29 (93.8%) have a regular menstrual periods, 
and only 2 patients (6.5%) showed menstrual disorder. Of 
the 32 normal subjects, 30 (93.8%) had regular menstrual 
periods, and only 2 (6.2%) had amenorrhea.
The prevalence of menstrual disorders in the PCOS 
group was significantly different in two groups (P < 0.01). 
In the physical examination, 86.6% of the PCOS group 
showed mild-to-moderate hirsutism and 41.9% had a mild 
hirsutism in the PCOA group, while only 15.6% of the 
normal group revealed mild hirsutism, which statistically 
showed a significant difference between the three groups 
(P ≤ 0.01).
As indicated in Table 1, the mean of ovarian volume 
in the PCOS group was higher than the PCOA group 
and the normal group, while the PCOA group showed 
more ovarian volume as compared to the normal group 
(P < 0.01). In the sonographic survey, gray scale findings 
revealed that 42 subjects (93.3%) in the PCOS group and 
26 (83.9%) in the PCOA group exhibited polycystic view 
in both ovaries, among the remaining individuals of both 
groups, only one polycystic ovary was seen.
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As shown in Table 2, there was no statistical difference 
in the distribution of follicles in the ovaries between the 
PCOS group and the PCOA group, although a significant 
difference was found between these groups and normal 
groups (P < 0.05). The mean number of follicles in the 
ovaries was recorded in the groups of PCOS (18.3 ± 6.4), 
PCOA (14.6 ± 3.7) and normal (7.1 ± 2.3). The mean number 
of ovarian follicles in the PCOS group was significantly 
higher compared with the PCOA group (P ≤ 0.05). In 
addition, this mean in PCOS and PCOA groups was 
statistically different from the normal group (P ≤ 0.001). It 
is worth noting that by Doppler ultrasound examination 
of uterine artery and ovarian stroma, the following results 
were obtained, where there was no statistically significant 
difference between the groups (P value ≥0.05).
There was no statistically significant difference in the 
blood flow RI of ovarian stroma (P ≥ 0.05). The statistical 
evaluation of the ultrasound findings revealed that in the 
PCOS group, the size of the affected ovaries was directly 
related to the number of ovarian follicles; in other words, 
with increasing ovarian volume, the number of ovarian 
follicles also increased (P ≤ 0.001). The PCOA group also 
showed a similar result. In both PCOS PCOA groups, 
the volume and number of ovarian follicles were not 
significantly associated with RI of ovarian stroma and 
RI of the uterine artery. In PCOS and PCOA groups, BMI 
and age did not correlate with ultrasound data (ovarian 
volume, number of follicles, RI of the uterine artery and 
ovarian stromal RI) (Tables 3 and 4).
Based on data presented herein, LH level increased in 
the majority of PCOS group than PCOA group (P ≤ 0.001). 
In other hormonal studies, no significant difference was 
found between the two groups (P ≥ 0.05). In the PCOS 
group, no relationship was found between the mean RI 
of the uterine artery and the RI of the ovarian stroma 
(P ≥ 0.05) (Table 5).
Among the individuals in the PCOS group, no 
association was found between the levels of hormonal 
factors (LH, free testosterone, DHEAS and 17-OH 
progesterone) with an average RI of the ovarian stroma 
(P ≥ 0.05). In the PCOS group, there was no relationship 
between the mean RI of the uterine artery and the 
hormonal factors. In the PCOS group, there was no 
correlation between ovarian volume and hormonal 
factors, and no correlation was found between the number 
of ovarian follicles and hormonal factors (Table 5).
In the PCOA group, there was a correlation between 
LH and ovarian volume (P = 0.03). LH levels have increased 
in individuals with more ovarian volume. The group also 
demonstrated that the levels of free testosterone, 17-OH 
progesterone and DHEAS hormones were also related 
to ovarian volume (P = 0.001). Moreover, the levels of 
free testosterone, 17-OH progesterone and DHEAS were 
related to ovarian follicles in the PCOA group (P = 0.001). 
The findings of this group suggested that there was no 
relationship between hormonal factors with ovarian 
Doppler index and uterine artery (P ≥ 0.05). Overall, the 
mean ovarian volume was significantly correlated with 
LH, free testosterone, 17-OH progesterone and DHEAS in 
both PCOS and PCOA groups (P = 0.03). The mean number 
of follicles was linked to the level of free testosterone, 
17-OH progesterone and DHEAS (P value = 0.01). However, 
Doppler RI in these two groups did not correlate with 
hormonal factors (P ≥ 0.05) (Table 5).
Discussion
In this study, we have found that the findings of 
transvaginal ultrasound together with clinical and 
laboratory outcomes, a more suitable pattern could be 
chosen for more accurate patient selection and, leading to 
Table 1 Average ovarian volume in each group.
Groups Number of subjects Mean volume of right ovary (cc) Mean volume of left ovary (cc) Mean volume of both ovaries (cc)
PCOS 45 15.5 ± 6.1 16.5 ± 5.3 16 ± 5.1
PCOA 31 12 ± 4.8 12.8 ± 4.8 12.4 ± 4.1
Normal 32 8.1 ± 3.2 8.2 ± 5 8.1 ± 3.6
Table 2 Distribution of follicles in the ovaries among the three groups.
Groups Number of subjects Number of peripherally located follicles Number of randomly distributed follicles
PCOS 45 37 8
PCOA 31 25 6
Normal 32 15 17
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timely treatment and reducing the complications of the 
disease.
PCOS is a heterozygote pathological condition, 
prominent manifestations of which are reproductive 
disorders, and is commonly associated with 
hyperandrogenism, obesity, hyperinsulinemia and insulin 
resistance (18). Ovarian morphologic examination with 
ultrasound is essential for PCOS diagnosis. A Doppler 
ultrasound is an ultrasound that measures the amount of 
blood flow in the vessels and tissues, and criteria for the 
uterine and ovarian arteries can be measured (19). In this 
study, a total of 108 had inclusion criteria, which were 
classified into three categories including PCOS group (45 
individuals), PCOA group (31 subjects) and normal group 
(32 subjects). The mean age for subjects in the PCOS 
group was 28.1 years, followed by 31 years for the PCOA 
group and 32 for the normal group. The mean BMI was 
calculated in PCOS (28.1 ± 4.6), PCOA (25.7 ± 3.7) and 
normal groups (24.3 ± 3.8) in kg/m2. BMI in the PCOS 
group was found to be significantly higher compared 
with the other two groups (P ≤ 0.01). A study by Lam et al. 
also reported a significant difference in BMI between the 
PCOS and normal group (20). Regarding the prevalence of 
menstrual disorders, the prevalence of amenorrhea in the 
PCOS group (88.8%) was significantly higher than that of 
the PCOA (6.5%) and normal (6.2%) groups. Therefore, 
anovulation and cyclic disorders was the most frequently 
detected types in the PCOS group, which was expected due 
to the choice of patients. These results were also consistent 
with the two Lam and Bostanci studies. The prevalence 
of menstrual disorders in the Caucasian PCOS group was 
reported to be 75 and 100%, respectively (16, 20). In terms 
of clinical evidence of hyperandrogenism, the study of 
hirsutism was performed in a clinical examination and 
subjects were classified according to the Ferriman–Gallwey 
Score in three degrees of mild, moderate and severe 
hirsutism. Based on the data presented herein, 86.6% of 
the PCOS group showed mild-to-moderate hirsutism and 
41.9% had a mild hirsutism in the PCOA group, while 
only 15.6% of the normal group revealed mild hirsutism, 
which statistically revealed a significant difference 
between the three groups (P ≤ 0.01). Therefore, hirsutism 
as criteria for clinical hyperandrogenism was clearly more 
prevalent in the PCOS group. Our research results were 
consistent with many studies. Fulghesu in Italy reported 
an increased rate of hirsutism in 418 patients with 
PCOS (48.9%), (21). There was no significant difference 
between the sonographic findings of bilateral ovaries 
in the present study. Therefore, the mean sonographic 
data of ovaries was evaluated and compared between the 
three groups. According to Rotterdam’s ultrasound index, 
10 cc is considered as a cut-off point for PCOS. The mean 
ovarian volume in the PCOS group was 16 cc compared 
to 12.4 cc in the PCOA group and 8.1 cc in the normal 
group. Accordingly, the ovaries in the group with PCOS 
had a higher mean volume than the other two groups. 
The PCOA group also had a higher volume of ovaries 
than the normal group. The findings of this study also 
revealed that the mean volumes in the two groups with 
polycystic view (PCOA and PCOS) were much higher, 
where Fulghesu’s study also confirmed this evidence (21).
The next factor was the number of follicles smaller 
than 9 mm in the ovary, and the mean values obtained 
in the PCOS group (18.3) were significantly higher than 
the two groups of PCOA (14.6) and the normal group 
(7.1). The difference in the number of follicles was 
statistically significant between the two groups of PCOA 
and the normal. Lam et al. also reported that the average 
number of follicles was 15 in the PCOS group and 5.5 in 
the normal group of Chinese women. They also reported 
that Caucasian women had an average of 16.3 follicles 
in the PCOS group vs 5.5 in the normal group, which 
is consistent with our findings (20, 22). The ovarian 
stroma and uterine artery of all patients were examined 
Table 3 Average RI of the uterine arteries in each group.
RI (right uterine artery) RI (left uterine artery) RI (mean of right and left uterine arteries)
PCOS 0.96 ± 0.46 0.97 ± 0.38 0.96 ± 0.42
PCOA 0.87 ± 0.89 0.87 ± 0.11 0.87 ± 0.08
Normal 0.87 ± 0.13 0.87 ± 0.13 0.87 ± 0.13
Table 4 Average RI of the ovarian stroma in each group.
RI (right ovarian stroma) RI (left ovarian stroma) RI (mean of right and left ovarian stroma)
PCOS 0.49 ± 0.08 0.51 ± 0.09 0.50 ± 0.07
PCOA 0.51 ± 0.06 0.49 ± 0.06 0.50 ± 0.05
Normal 0.48 ± 0.09 0.51 ± 0.08 0.50 ± 0.04
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by 2D color Doppler and wave spectra were consequently 
recorded.
The arterial RI derived from the spectrum of ovarian 
stroma and uterine arteries on each side were calculated 
separately. The findings of the two sides showed no 
significant difference in the statistical scale. Therefore, the 
average RI of ovarian stroma and RI of the uterine arteries 
on both sides were statistically analyzed. In the statistical 
analysis, there was a significant difference between the 
Doppler indexes in these three groups, which is consistent 
with the study of Lakhani et al. (3).
The volume of the ovary and the number of follicles 
were associated with amenorrhea and the incidence of 
hirsutism; furthermore, higher ovarian volume and higher 
follicle count were found to markedly increase menstrual 
disorders and hirsutism, which this pathophysiological 
finding revealed ovarian morphology with clinical 
manifestations of hyperandrogenism. However, in this 
study, RI of uterine artery and ovarian stroma were not 
correlated with menstrual disorder and hirsutism. These 
findings were similar to those of Lam et  al., (20) and 
(22), that there has been no correlation between ovarian 
volume, follicle count, RI of uterine and ovarian arteries 
with anovulation and hirsutism in PCOS patients (20, 22).
Fulghesu et  al. evaluated ultrasound findings with 
hormonal values and they reported that ovarian volume 
was associated with LH levels in people with PCOS, which 
showed similar results to the current study outcomes. On 
the other hand, there was a positive correlation between 
the numbers of follicles with 17-OH-progesterone in 
aforementioned study, which was revealed in the present 
study (21).
In conclusion, the present study was conducted to 
evaluate the levels of LH, FSH and androgenic hormones 
free testosterone, 17-OH-progesterone and DHEAS. The 
percentage of LH above normal in the PCOS group was 
significantly higher than the PCOA group (48.9 vs 12.5%). 
This difference was not significant in other hormones.
Overall, the mean ovarian volume of both PCOS and 
PCOA groups was positively associated with abnormal 
levels of LH, free testosterone, progesterone 17-OH and 
DHEAS. In addition, the number of follicles was positively 
associated with abnormal amounts of free testosterone, 
progesterone-OH-17 and DHEAS. Meanwhile, there was 
no association between Doppler indexes and hormonal 
factors.
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